PHENAZOPYRIDINE HYDROCHLORIDE
- Product NDC
- 62135-403
- 11-digit product format
- 621350403
- Labeler code
- 62135
- Product ID
- 62135-403_45ae56cd-d6c6-3ad2-e063-6394a90a8ebf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PHENAZOPYRIDINE HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2011-08-23
- Substance
- PHENAZOPYRIDINE HYDROCHLORIDE
- Active strength
- 100 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- PHENAZOPYRIDINE HYDROCHLORIDE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PHENAZOPYRIDINE HYDROCHLORIDE | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 0EWG668W17 |
| Rxcui | 1094104, 1094107 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-403-60 | PHENAZOPYRIDINE HYDROCHLORIDE | 60 in 1 BOTTLE | TABLET | 60 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-403 | PHENAZOPYRIDINE HYDROCHLORIDE TABLET [CHARTWELL RX, LLC] | 2 | Current NDC, Legacy NDC, 1 package rows | 20241025_9ed3cf8c-e1c1-4290-b094-25ac6f7a9a56.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 62135-403-60 | 62135040360 | 60 TABLET in 1 BOTTLE (62135-403-60) | 60 tablet | 2022-09-01 | 0000-00-00 | No | No | Current |